Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group : A Danish nationwide cohort study
Copyright © 2022 Katzenstein, Rasmussen, Drabe, Larsen, Hansen, Stærkind, Knudsen, Hansen and Obel..
The risk of severe adult respiratory coronavirus-2 (SARS-CoV-2) infection and the course of the infection among individuals with common variable immunodeficiency (CVID) relative to the general population have been a matter of debate. We conducted a Danish nationwide study comparing the timing of SARS-CoV-2 vaccination, the risk of first confirmed SARS-CoV-2 infection, re-infection, and the outcome of infection among individuals with CVID relative to an age- and gender matched control group. Cox regression was used to calculate incidence rate ratios. The CVID patients received SARS-CoV-2 vaccinations earlier than those included in the population control group. Even so, the risks of both first infection and re-infection were increased among the individuals with CVID. The CVID group also had increased risk for hospital contacts due to SARS-CoV-2 infection relative to the general population. However, reassuringly, the risk of mechanical ventilation and death did not differ between the groups, but the numbers were low in both groups, making the estimates uncertain. Though this is the largest study to investigate the risk of SARS-CoV-2 infections and outcomes hereof among individuals with CVID relative to the general population, we cannot rule out minor differences in severity, which might only be detectable with an even larger sample size.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Frontiers in immunology - 13(2022) vom: 03., Seite 994253 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Katzenstein, Terese L [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.10.2022 Date Revised 06.11.2023 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fimmu.2022.994253 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347266975 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347266975 | ||
| 003 | DE-627 | ||
| 005 | 20231226205359.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2022.994253 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347266975 | ||
| 035 | |a (NLM)36211430 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Katzenstein, Terese L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group |b A Danish nationwide cohort study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.10.2022 | ||
| 500 | |a Date Revised 06.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Katzenstein, Rasmussen, Drabe, Larsen, Hansen, Stærkind, Knudsen, Hansen and Obel. | ||
| 520 | |a The risk of severe adult respiratory coronavirus-2 (SARS-CoV-2) infection and the course of the infection among individuals with common variable immunodeficiency (CVID) relative to the general population have been a matter of debate. We conducted a Danish nationwide study comparing the timing of SARS-CoV-2 vaccination, the risk of first confirmed SARS-CoV-2 infection, re-infection, and the outcome of infection among individuals with CVID relative to an age- and gender matched control group. Cox regression was used to calculate incidence rate ratios. The CVID patients received SARS-CoV-2 vaccinations earlier than those included in the population control group. Even so, the risks of both first infection and re-infection were increased among the individuals with CVID. The CVID group also had increased risk for hospital contacts due to SARS-CoV-2 infection relative to the general population. However, reassuringly, the risk of mechanical ventilation and death did not differ between the groups, but the numbers were low in both groups, making the estimates uncertain. Though this is the largest study to investigate the risk of SARS-CoV-2 infections and outcomes hereof among individuals with CVID relative to the general population, we cannot rule out minor differences in severity, which might only be detectable with an even larger sample size | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a clinical outcome | |
| 650 | 4 | |a common variable immunodeficiency (CVID) | |
| 650 | 4 | |a inborn errors of immunity (IEI) | |
| 650 | 4 | |a severe adult respiratory coronavirus-2 (SARS-CoV-2) | |
| 650 | 4 | |a severe novel coronavirus 2019 (COVID-19) | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Rasmussen, Line D |e verfasserin |4 aut | |
| 700 | 1 | |a Drabe, Camilla Helberg |e verfasserin |4 aut | |
| 700 | 1 | |a Larsen, Carsten Schade |e verfasserin |4 aut | |
| 700 | 1 | |a Hansen, Ann-Brit Eg |e verfasserin |4 aut | |
| 700 | 1 | |a Stærkind, Mette |e verfasserin |4 aut | |
| 700 | 1 | |a Knudsen, Lene Surland |e verfasserin |4 aut | |
| 700 | 1 | |a Hansen, Christian Holm |e verfasserin |4 aut | |
| 700 | 1 | |a Obel, Niels |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 13(2022) vom: 03., Seite 994253 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g day:03 |g pages:994253 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2022.994253 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |b 03 |h 994253 | ||